share_log

Critical Insights From Abbott Laboratories Analyst Ratings: What You Need To Know

Critical Insights From Abbott Laboratories Analyst Ratings: What You Need To Know

雅培實驗室分析師評級的關鍵見解:你需要知道的
Benzinga ·  05/22 14:00
Throughout the last three months, 5 analysts have evaluated Abbott Laboratories (NYSE:ABT), offering a diverse set of opinions from bullish to bearish.
在過去的三個月中,有5位分析師對雅培實驗室(紐約證券交易所代碼:ABT)進行了評估,提供了從看漲到看跌的不同觀點。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表簡要概述了分析師最近的評級,提供了對過去30天情緒變化的見解,並與前幾個月進行了比較以獲得整體視角。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $127.4, a high estimate of $140.00, and a low estimate of $119.00. A decline of 0.93% from the prior average price target is evident in the current average.
分析師12個月目標股價的見解得以公佈,平均目標股價爲127.4美元,最高估計爲140.00美元,低估值爲119.00美元。目前的平均價格比先前的平均目標股價下降了0.93%。
Deciphering Analyst Ratings: An In-Depth Analysis
解密分析師評級:深度分析
A...
對...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論